Taking account of the average cost of treating rabies patients and dealing with the additional deaths, Taylor and his colleagues concluded that the vulture decline caused by diclofenac indirectly cost India $34bn (£28bn) between 1993 and 2006, equivalent to 3.6% of the country"s GDP in 2006.